Source: Scientifc Reports. Unidade: ICB
Subjects: FARMACOLOGIA, HIPERTENSÃO PULMONAR, AORTA DE ANIMAL, CAMUNDONGOS, CÉLULAS ENDOTELIAIS, MÚSCULO LISO VASCULAR, VASODILATAÇÃO, FÁRMACOS (SISTEMA CARDIOVASCULAR), MEDICAMENTO
ABNT
MOHAMED, Nura A.; SHALA, Blerina Ahmetaj; SHALA, Fisnik; et al. Studies on metal–organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension. Scientifc Reports, London, Nature Publishing Group, v. 11, p. 8 , 2021. Disponível em: < https://doi.org/10.1038/s41598-021-83423-6 > DOI: 10.1038/s41598-021-83423-6.APA
Mohamed, N. A., Shala, B. A., Shala, F., Kirkby, N. S., Jennings, L., Ansari, D. E. A., et al. (2021). Studies on metal–organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension. Scientifc Reports, 11, 8 . doi:10.1038/s41598-021-83423-6NLM
Mohamed NA, Shala BA, Shala F, Kirkby NS, Jennings L, Ansari DEA, Davies RP, Lickiss PD, Mitchell JA, Saleh HA, Kameno Y, Marei I, Nucci G de. Studies on metal–organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension [Internet]. Scientifc Reports. 2021 ; 11 8 .Available from: https://doi.org/10.1038/s41598-021-83423-6Vancouver
Mohamed NA, Shala BA, Shala F, Kirkby NS, Jennings L, Ansari DEA, Davies RP, Lickiss PD, Mitchell JA, Saleh HA, Kameno Y, Marei I, Nucci G de. Studies on metal–organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension [Internet]. Scientifc Reports. 2021 ; 11 8 .Available from: https://doi.org/10.1038/s41598-021-83423-6